First, a visual assessment of the emulsion was performed at regular intervals when the formulated vaccines were stored at Screening high throughput screening 4 °C for 12 months. At the initial time point, the finished emulsions appeared white or as an off-white, opaque liquid. After storage at 4 °C for 1 week, a transparent oil-like layer at the top of the emulsion with a white opaque layer

at the bottom was observed. Following gentle shaking, the two phases were easily combined and again appeared as a white opaque liquid whose drop and conductivity tests were indistinguishable from fresh sample (data not shown). To investigate the integrity of the antigen in the emulsion following storage after 1 year, the protein was extracted and analyzed by SDS-PAGE and Western blot analysis. As shown in Fig. 1, no degradation bands from the emulsion-extracted protein were observed on the SDS-PAGE gels visualized with Coomassie when emulsions were stored at 4 °C for 1 year. Silver staining with extracted protein stored for more than 2 years also showed no degradation (Fig. 2). Finally, the anti-MSP1-19 monoclonal antibody mAb5.2 bound to the entire protein and not to degradation products (Fig. 3). To test the integrity of PfCP-2.9 in emulsions stored at different temperatures,

the vaccine emulsions were stored at 25 and 37 °C for various periods. As shown in Fig 4, the protein extracted from the emulsion was stable for up to

3 months when it was tuclazepam stored at 25 °C and some degradation was observed selleck inhibitor by SDS-PAGE gel after 1 month storage at 37 °C and degradation increased dramatically after 3 months at this temperature. Some protein aggregation was observed following extraction from emulsion as noted by SDS-PAGE and Western blot analyses. Protein multimers increased over time and as the storage temperature increased (Fig. 2 and Fig. 4). It is likely that protein aggregation was not disulfide band dependent since it was not susceptible to reducing conditions (Fig. 1D, lane R). However, aggregated protein was recognized by mAb5.2 as shown in Fig. 3, indicating that the multimers retained their critical conformational epitope intact. To quantitatively analyze the aggregated protein, we used the gel-HPLC method which allowed for the separation of materials such as proteins or chemical reagents based on their molecular weights. As shown in Fig. 5, the peak pattern in Fig. 5A was for that of the extract from the blank emulsion that lacked the PfCPP-2.9 protein whereas that of the extract from vaccine emulsion containing the protein in Fig. 5B showed two additional peaks (the two additional peaks corresponded to PfCPP-2.9 and PfCPP-2.9 dimers). Analysis of the area under the respective peaks demonstrated 7.6% dimmers and 92.4% monomers.